2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus
Huiqi Yin(Chinese Academy of Medical Sciences & Peking Union Medical College), Qianjin Lu(Central South University), Ming Zhao(Central South University), Zijun Wang(Central South University), Xinyu Fan(China Medical University), Xiwei Feng(Chinese Academy of Medical Sciences & Peking Union Medical College), Lingyu Gao(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Wu(Chinese Academy of Medical Sciences & Peking Union Medical College), Junpeng Zhao(Chinese Academy of Medical Sciences & Peking Union Medical College), Liming Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yijing Zhan(Chinese Academy of Medical Sciences & Peking Union Medical College), Meiling Zheng(Macau University of Science and Technology)
Cited by 9
Related Papers
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus
|Nature Genetics|2009|951
Demethylation of <i>CD40LG</i> on the Inactive X in T Cells from Women with Lupus
|The Journal of Immunology|2007|466
Induced Regulatory T Cells: Their Development, Stability, and Applications
|Trends in Immunology|2016|451
TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
|Clinical Reviews in Allergy & Immunology|2013|372